Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
PORTOLA PHARMACEUTICALS INC
| Metric | PORTOLA PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $117M |
| Net income (latest) | −$78M |
| Operating margin | −232.6% |
| Net margin | −67.0% |
| Return on equity | −60.2% |
| Return on assets | −13.5% |
| Return on capital (ROCE) | −57.0% |
| Debt / equity | 3.46× |
| Revenue growth (YoY) | 190.7% |
| Altman Z″ (distress) | -9.00 |
| Accruals / assets | 27.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.